Skip links
Companies
› Germany › Salutas Pharma GmbH
Company registry profile
Salutas Pharma GmbH logo

Salutas Pharma GmbH

Active

Salutas Pharma GmbH is a German limited liability company (Gesellschaft mit beschränkter Haftung) entered in the commercial register at Amtsgericht Stendal under HRB 105793, with its registered seat in Barleben, Saxony-Anhalt, and a business address at Otto-von-Guericke-Allee 1, 39179 Barleben. The structured register extract retrieved on 29 September 2026 shows the record as current, carrying 43 entries with the most recent dated 16 March 2026. Its registered object is the manufacture and distribution of medicinal products and other pharmaceutical and biological preparations, and its registered share capital is EUR 42,100,000.

Two fields in the information card above need qualifying. The incorporation date shown as 1 January 2007 is a year-level placeholder rather than a registry date: the register records the articles of association as dated 21 December 1990 and the day of first registration as 13 August 1993, the file having been carried over from Amtsgericht Magdeburg (HRB 5795). The legal form is a German GmbH, not the UK-style private limited company the card names.

Salutas Pharma GmbH manufactures, packages and distributes finished medicines from two sites in Saxony-Anhalt. Barleben produces solid oral dosage forms, including tablets, film-coated tablets and capsules and highly potent oncology medicines; Osterweddingen produces and packages semi-solid forms such as ointments, creams and gels, and low-dose hormone tablets. The company states that it converts around 100 active pharmaceutical ingredients into roughly 3,000 finished products, exports to about 100 countries and also manufactures to order for third-party customers. Its published 2025 production figures are 8 billion tablets and capsules in bulk, around 10 billion packaged units, 220 million packs and 240 million units of special production, across roughly 17,300 square metres of production space in Barleben and 5,300 in Osterweddingen. Its own site gives a workforce of about 1,400 across the two locations, with no reporting date attached.

Salutas Pharma GmbH has not deposited its own annual accounts in the Bundesanzeiger. Its accounting publications for financial years 2014 to 2021 are exemption notices under sections 264(3) and 264b HGB, the last published on 29 October 2021, and no later filing appears, so entity-level revenue, profit and employee figures are not available from a free primary source. The company has no stock-exchange listing. On 26 June 2026 the Federal Chancellor and the Minister-President of Saxony-Anhalt visited the Barleben plant, which the Federal Government described as producing around ten billion capsules and tablets a year for export worldwide.

Sources

  • Gemeinsames Registerportal der Länder (handelsregister.de) — Amtsgericht Stendal HRB 105793, Strukturierter Registerinhalt (SI), extract dated 29 September 2026, https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Bundesanzeiger — publication index for Salutas Pharma GmbH, Barleben (filings of 25 February 2015 to 29 October 2021), https://www.bundesanzeiger.de/pub/de/suche. Retrieved 29 September 2026.
  • Sandoz — “Salutas Pharma GmbH”, company site (2025 production figures, product range, workforce), https://www.sandoz.com/de-de/ueber-sandoz/unser-unternehmen/salutas/. Undated page; retrieved 29 September 2026.
  • Sandoz — “Barleben und Osterweddingen”, site page (the destination of the company domain salutas.de), https://www.sandoz.com/de-de/ueber-uns/standorte-deutschland/barleben-und-osterweddingen/. Undated page; retrieved 29 September 2026.
  • Presse- und Informationsamt der Bundesregierung — “Herausragendes Beispiel für zukunftsfähige Arbeitsplätze”, press statement at Salutas Pharma, published 26 June 2026, https://www.bundesregierung.de/breg-de/aktuelles/bundeskanzler-salutas-pharma-2445354. Retrieved 29 September 2026.

From the registry

Registration details

Registration No.
HRB 105793 Stendal
Incorporation Date
Not disclosed
Company Type
Not disclosed
Address
Barleben, Germany
Website
salutas.de/
Source: Handelsregister (Commercial Register)Registry coverage

Shareholders

3

Shareholders of Salutas Pharma GmbH

Salutas Pharma GmbH has one shareholder. The Liste der Gesellschafter (shareholder list) held in the register folder of Amtsgericht Stendal for HRB 105793 — drawn up on 10 March 2020, received by the court on 25 March 2020 and admitted to the register folder on 26 March 2020 — records Hexal Aktiengesellschaft, Holzkirchen (Landkreis Miesbach), Amtsgericht München HRB 110375, as the holder of all three shares in issue. The list states in terms that Hexal Aktiengesellschaft “hält somit insgesamt Geschäftsanteile mit den lfd. Nrn. 1 bis 3 mit einem Nominalbetrag in Höhe von insgesamt 42.100.000,– € und einer prozentualen Beteiligung von 100 %”. The three parcels are share no. 1, nominal EUR 41,747,000 (99.16%); share no. 2, nominal EUR 253,000 (0.6%); and share no. 3, nominal EUR 100,000 (0.24%). The holding is direct, in ordinary share capital, and the shares are not divided into classes.

The position is corroborated independently by Sandoz Group AG’s audited consolidated financial statements for the year ended 31 December 2025, whose principal-subsidiaries note lists Salutas Pharma GmbH, Barleben, with share capital of EUR 42.1 million and an equity interest of 100%.

A defect in the underlying feed is worth recording: the stored shareholder data for this page holds three rows, all naming Hexal Aktiengesellschaft, which reads as three separate shareholders. They are three Geschäftsanteile of a single shareholder, and the percentages 99.16, 0.6 and 0.24 are parcel shares that sum to the whole company.

Ultimate beneficial ownership

No natural-person beneficial owner could be verified. Germany’s Transparenzregister has been closed to public inspection since the Court of Justice of the European Union ruled on 22 November 2022 (Joined Cases C-37/20 and C-601/20) that general public access to beneficial-ownership registers is invalid, so the statutory German UBO record cannot be consulted. The documented ownership chain runs from Hexal Aktiengesellschaft to Sandoz Group AG, Basel (CHE-433.164.136), a company whose shares are listed and widely held; none of the sources consulted identifies a natural person holding a qualifying interest in Salutas Pharma GmbH, directly or indirectly.

Data availability

Shareholder information for this entity is Full: German law requires a Gesellschafterliste to be filed under section 40 GmbHG, and handelsregister.de makes it retrievable free of charge with names, nominal amounts and percentages. Beneficial-ownership information is Restricted — the register exists but is not open to public inspection. The shareholder list in the file is dated 10 March 2020; a later list would have been filed had the holding changed, and none appears in the register folder, but the absence of a later filing is not itself proof that nothing has changed.

Sources

  • Amtsgericht Stendal, HRB 105793 — “Liste der Gesellschafter” of Salutas Pharma GmbH, created 10 March 2020, received 25 March 2020, admitted to the register folder 26 March 2020, retrieved from the document folder (DK) at https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Gemeinsames Registerportal der Länder (handelsregister.de) — Amtsgericht Stendal HRB 105793, Strukturierter Registerinhalt (SI), share capital EUR 42,100,000, extract dated 29 September 2026, https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Sandoz Group AG — Financial Report 2025, note 34 “Principal Group subsidiaries”, published 24 February 2026, https://sandoz-com.cms.sandoz.com/sites/default/files/2026-02/Sandoz%20Financial%20Report%202025.pdf. Retrieved 29 September 2026.
  • Court of Justice of the European Union — Judgment of 22 November 2022 in Joined Cases C-37/20 and C-601/20, WM and Sovim SA v Luxembourg Business Registers, https://curia.europa.eu/juris/liste.jsf?num=C-37/20. Retrieved 29 September 2026.
  • GLEIF — LEI record 5493000JWK6XWFEUD320, Sandoz Group AG, Basel, registered as CHE433164136, https://search.gleif.org/#/record/5493000JWK6XWFEUD320. Retrieved 29 September 2026.

Data-provider feed — rows as supplied to Zavia for Handelsregister (Commercial Register), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Hexal Aktiengesellschaft 99.2% Handelsregister (Commercial Register)
Hexal Aktiengesellschaft 0.6% Handelsregister (Commercial Register)

Officers

37

Directors and officers of Salutas Pharma GmbH

The structured register content (Strukturierter Registerinhalt) for Amtsgericht Stendal HRB 105793, extracted on 29 September 2026, records five current officeholders in two distinct legal roles. Two are Geschäftsführer (managing directors), the statutory representative organ of a GmbH: Claudia Lövenich and Grit Antje Müller. Three are Prokuristen — holders of Prokura, the commercial power of representation under sections 48 ff. of the German Commercial Code, which is an agency power and not board membership: Gregor Markus Tamm, Folker Heinicke and Katrin Seidel.

The general rule of representation on the register is that if only one Geschäftsführer is appointed he or she represents the company alone, and that where several are appointed the company is represented by two Geschäftsführer jointly, or by one Geschäftsführer together with a Prokurist. Each of the three Prokuristen is entered with Gesamtprokura, exercisable jointly with a Geschäftsführer or with another Prokurist. No officeholder can therefore bind Salutas Pharma GmbH alone on the current entry.

Salutas Pharma GmbH also has an Aufsichtsrat (supervisory board). The register publications for HRB 105793 record that a list of supervisory-board members was filed with the court and announced on 31 March 2023 (announced 19 April 2023), 15 May 2023, 1 September 2023, 16 July 2025 and, most recently, 11 June 2026. A Bundesanzeiger notice published by the company on 7 October 2016 shows that the employee-side members are elected under section 8 of the Drittelbeteiligungsgesetz. The members’ names are not carried in the free structured extract.

Data availability

Officer information for this entity is Current only. The free structured extract lists every current officeholder with the exact local role and the rule of representation, but carries no appointment or termination dates; dated appointment history requires the chronological (CD) or historical (HD) printout. The German commercial register does not record nationality, so nationality is Not disclosed for all five officeholders, and it must not be inferred from the places of residence the register gives. Occupation is likewise not recorded.

The provider feed behind this page differs from the register in several ways and should not be relied on. It holds 38 rows against the five current officeholders, with no distinction preserved between Geschäftsführer and Prokurist — every Prokurist is flattened to “Officer”. Two rows are marked as no longer in office but carry no termination date at all (Helmut Kolodziej, shown as appointed 1 December 2006, and Rudolf Walter Schlott, shown as appointed 16 September 2020); neither appears in the current register. One person appears twice under the same name and birth month, once with a termination date of 31 March 2023 and once without. The stored date of birth for one of the three Prokuristen does not match the register entry, and for another it is absent. The five rows the feed marks as current do match the register exactly.

Sources

  • Gemeinsames Registerportal der Länder (handelsregister.de) — Amtsgericht Stendal HRB 105793, Strukturierter Registerinhalt (SI): current officeholders, roles and rule of representation, extract dated 29 September 2026, https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Gemeinsames Registerportal der Länder (handelsregister.de) — Veröffentlichungen for Amtsgericht Stendal HRB 105793, “Einreichung neuer Dokumente: Eine Liste der Mitglieder des Aufsichtsrates wurde zum Handelsregister eingereicht”, announcements of 19 April 2023, 15 May 2023, 1 September 2023, 16 July 2025 and 11 June 2026, https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Bundesanzeiger — Salutas Pharma GmbH, Barleben, Gesellschaftsbekanntmachung “Aufsichtsrat: Bekanntmachung über die Wahl der Aufsichtsratsmitglieder der Arbeitnehmer nach § 8 DrittelbG”, published 7 October 2016, https://www.bundesanzeiger.de/pub/de/suche. Retrieved 29 September 2026.

Data-provider feed — rows as supplied to Zavia for Handelsregister (Commercial Register), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

CL
Claudia Lövenich ACTIVE

Appointed
2019-07-09
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

GA
Grit Antje Müller ACTIVE

Appointed
2021-12-06
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

GM
Gregor Markus Tamm ACTIVE

Appointed
2022-05-02
Residence
🇩🇪 Germany
Occupation
Officer

KS
Katrin Seidel ACTIVE

Residence
🇩🇪 Germany
Occupation
Officer

FH
Folker Heinicke ACTIVE

Residence
🇩🇪 Germany
Occupation
Officer

OJ
Oliver Joachim Schott RESIGNED

Appointed
2006-07-19
Resigned
2007-06-21
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

AS
Antje Schleußner RESIGNED

Appointed
2006-07-19
Resigned
2009-03-13
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

FP
Frank Peter Elsen RESIGNED

Appointed
2007-06-21
Resigned
2011-05-18
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

NM
Norbert Marquardt RESIGNED

Appointed
2008-07-17
Resigned
2015-04-24
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

TA
Thomas Alexander Baur RESIGNED

Appointed
2011-08-25
Resigned
2014-06-26
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

JS
Jeffrey Simon Francis RESIGNED

Appointed
2015-02-04
Resigned
2016-09-09
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

BG
Burkart Gert Broede RESIGNED

Appointed
2015-02-04
Resigned
2019-07-09
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

DI
Davide Improta RESIGNED

Appointed
2016-09-09
Resigned
2019-06-24
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

CT
Christian Thoralf Langwich RESIGNED

Appointed
2018-09-25
Resigned
2020-03-05
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

JK
Joao Keller RESIGNED

Appointed
2019-06-24
Resigned
2021-12-06
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

RW
Rudolf Walter Schlott RESIGNED

Appointed
2020-09-16
Residence
🇩🇪 Germany
Occupation
Geschäftsführer (managing director)

CH
Cathleen Hohenberger RESIGNED

Appointed
2006-07-19
Residence
🇩🇪 Germany
Occupation
Officer

GB
Gerhard Bauer RESIGNED

Appointed
2006-07-19
Residence
🇩🇪 Germany
Occupation
Officer

WS
Wolfram Schütze RESIGNED

Appointed
2006-07-19
Resigned
2012-02-23
Residence
🇩🇪 Germany
Occupation
Officer

GB
Gerhard Bauer RESIGNED

Appointed
2006-09-21
Residence
🇩🇪 Germany
Occupation
Officer

JO
Jürgen Oed RESIGNED

Appointed
2006-09-21
Resigned
2007-11-28
Residence
🇩🇪 Germany
Occupation
Officer

KM
Karin Maria Günther RESIGNED

Appointed
2006-10-12
Resigned
2009-03-13
Residence
🇩🇪 Germany
Occupation
Officer

AF
Alfred Friedrich Veit RESIGNED

Appointed
2006-10-12
Resigned
2013-10-11
Residence
🇩🇪 Germany
Occupation
Officer

HK
Helmut Kolodziej RESIGNED

Appointed
2006-12-01
Residence
🇩🇪 Germany
Occupation
Officer

MI
Matthias Ihle RESIGNED

Appointed
2007-11-28
Resigned
2010-06-24
Residence
🇩🇪 Germany
Occupation
Officer

EL
Edgar Leyrer RESIGNED

Appointed
2007-11-28
Resigned
2011-05-18
Residence
🇩🇪 Germany
Occupation
Officer

KH
Klaus Herzig RESIGNED

Appointed
2007-11-28
Resigned
2012-02-23
Residence
🇩🇪 Germany
Occupation
Officer

VN
Volker Nürnberg RESIGNED

Appointed
2010-06-24
Resigned
2012-02-23
Residence
🇩🇪 Germany
Occupation
Officer

FW
Fred Wulfgramm RESIGNED

Appointed
2010-06-24
Resigned
2015-03-26
Residence
🇩🇪 Germany
Occupation
Officer

NS
Norman Scheider RESIGNED

Appointed
2010-06-24
Resigned
2016-02-25
Residence
🇩🇪 Germany
Occupation
Officer

NW
Notker Walter Karpf RESIGNED

Appointed
2010-06-24
Resigned
2017-08-24
Residence
🇩🇪 Germany
Occupation
Officer

GM
Gert Magnus Von Stackelberg RESIGNED

Appointed
2012-02-23
Resigned
2015-11-12
Residence
🇩🇪 Germany
Occupation
Officer

JU
Jörg Ullrich Schöfthaler RESIGNED

Appointed
2012-02-23
Resigned
2022-05-02
Residence
🇩🇪 Germany
Occupation
Officer

IN
Irmgard Neuper RESIGNED

Appointed
2013-10-11
Resigned
2015-06-04
Residence
🇩🇪 Germany
Occupation
Officer

LR
Lutz Rüdiger Springer RESIGNED

Appointed
2014-11-27
Resigned
2019-02-04
Residence
🇩🇪 Germany
Occupation
Officer

CC
Christian Caderas RESIGNED

Appointed
2015-05-21
Resigned
2017-01-19
Residence
🇩🇪 Germany
Occupation
Officer

TS
Thomas Seib RESIGNED

Appointed
2015-06-04
Resigned
2016-04-14
Residence
🇩🇪 Germany
Occupation
Officer

Group Structure

Group structure of Salutas Pharma GmbH

Salutas Pharma GmbH is not independent. It is a wholly owned German subsidiary within the Sandoz group, and the chain above it is documented at every step by primary sources rather than inferred. Its immediate parent is Hexal Aktiengesellschaft, Holzkirchen (Amtsgericht München HRB 110375), which holds 100% of the EUR 42,100,000 share capital. Hexal Aktiengesellschaft is itself part of the German sub-group headed by Sandoz Deutschland GmbH, Nuremberg, and the ultimate parent is Sandoz Group AG, Basel (CHE-433.164.136), whose shares are listed on the SIX Swiss Exchange. Control of Salutas Pharma GmbH does not rest on shareholding alone: the register records a Beherrschungs- und Ergebnisabführungsvertrag — a combined domination and profit-transfer agreement — with Hexal Aktiengesellschaft, concluded on 21 April 2005 and amended on 27/30 July 2012, still in force on the extract of 29 September 2026. Salutas Pharma GmbH has two verified sister companies and no recorded subsidiaries of its own. The register information is current to 29 September 2026; the group information is current to 31 December 2025 (audited) and 12 February 2026 (company notice).

Verified corporate relationships

Entity Country Registration number Relationship Ownership Status Information date
Hexal Aktiengesellschaft, Holzkirchen Germany HRB 110375 (Amtsgericht München) Immediate parent 100% of share capital (three shares, nominal EUR 42,100,000 in total); also party to a domination and profit-transfer agreement Current Shareholder list 10 Mar 2020; agreement still on the register 29 Sep 2026
Sandoz Deutschland GmbH, Nuremberg Germany Not stated in the sources used Controlling German group company (herrschendes Konzernunternehmen) over Hexal Aktiengesellschaft and its subsidiaries Ownership percentage not disclosed in the sources used Current 12 Feb 2026
Sandoz Group AG, Basel Switzerland CHE-433.164.136 Ultimate parent 100% equity interest (voting rights) in Salutas Pharma GmbH Current 31 Dec 2025 (audited)
1 A Pharma GmbH, Holzkirchen Germany Not stated in the sources used Sister company (subsidiary of Hexal Aktiengesellschaft) Ownership percentage not disclosed in the sources used Current 12 Feb 2026
AEROPHARM GmbH, Rudolstadt Germany Not stated in the sources used Sister company (subsidiary of Hexal Aktiengesellschaft) Ownership percentage not disclosed in the sources used Current 12 Feb 2026
Novartis Deutschland GmbH, Nuremberg (formerly Wehr) Germany Not stated in the sources used Historical: consolidating parent named in the section 264(3) HGB exemption notices Ownership percentage not disclosed in the sources used Historical Financial years 2014 to 2021; last notice published 29 Oct 2021
Salutas PWO GmbH, Osterweddingen Germany HRB 114386 (Amtsgericht Stendal) Historical: merged into Salutas Pharma GmbH Merged in full Ceased Merger agreement 25 May 2007
Salutas Logistik GmbH Germany HRB 9876 (Amtsgericht Magdeburg) Historical: merged into Salutas Pharma GmbH Merged in full Ceased Merger agreement 13 Aug 2003

Recent structural changes

  • 4 October 2023 — change of ultimate parent. Sandoz Group AG separated from Novartis AG and became a stand-alone listed company; Sandoz’s own 2025 financial statements date the spin-off to 4 October 2023. Up to financial year 2021 the entity’s HGB exemption notices named Novartis Deutschland GmbH as the consolidating parent; Sandoz Group AG’s 2025 consolidated statements now list Salutas Pharma GmbH as a Sandoz subsidiary. The immediate shareholder, Hexal Aktiengesellschaft, did not change.
  • 12 February 2026 — group-level position restated. In a Bundesanzeiger company notice opening a Statusverfahren under sections 97 ff. of the German Stock Corporation Act, the management board of Hexal Aktiengesellschaft named Salutas Pharma GmbH, Barleben among its subsidiaries and stated that Hexal Aktiengesellschaft and those subsidiaries are combined under the single management (einheitliche Leitung) of Sandoz Deutschland GmbH, Nuremberg, as the controlling group company.

Data availability

Corporate-linkage information for this entity is Full on the parent side and Partial elsewhere: the immediate parent and its exact percentage come from a filed shareholder list, the controlling relationship from the register itself, and the ultimate parent with a stated 100% equity interest from audited consolidated accounts. Registration numbers and percentages for the intermediate and sister entities are not published in the sources used and are shown as not disclosed rather than assumed. No subsidiaries of Salutas Pharma GmbH were found in the register, in the shareholder list or in the Sandoz principal-subsidiaries note; that is an absence of evidence, not proof that none exists. The provider’s stored group tree places Salutas Pharma GmbH correctly under Hexal Aktiengesellschaft, Sandoz Deutschland GmbH and Sandoz Group AG, but it carries no ownership percentages and no dates, so nothing in it distinguishes a wholly owned subsidiary from a minority holding.

Sources

  • Amtsgericht Stendal, HRB 105793 — “Liste der Gesellschafter” of Salutas Pharma GmbH, created 10 March 2020, admitted to the register folder 26 March 2020, https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Gemeinsames Registerportal der Länder (handelsregister.de) — Amtsgericht Stendal HRB 105793, Strukturierter Registerinhalt (SI): Unternehmensvertrag entry recording the Beherrschungs- und Ergebnisabführungsvertrag with Hexal Aktiengesellschaft of 21 April 2005, amended 27/30 July 2012, and the merger entries of 2003, 2004, 2006 and 2007, extract dated 29 September 2026, https://www.handelsregister.de/rp_web/welcome.xhtml. Retrieved 29 September 2026.
  • Bundesanzeiger — HEXAL Aktiengesellschaft, Holzkirchen, “Bekanntmachung des Vorstands über die Zusammensetzung des Aufsichtsrats und Einleitung eines Statusverfahren nach §§ 97 ff. Aktiengesetz”, dated Holzkirchen 5 February 2026 and published 12 February 2026, https://www.bundesanzeiger.de/pub/de/suche. Retrieved 29 September 2026.
  • Bundesanzeiger — Salutas Pharma GmbH, Barleben, publications under sections 264(3) and 264b HGB naming Novartis Deutschland GmbH as consolidating parent, financial years 2014 to 2021, last published 29 October 2021, https://www.bundesanzeiger.de/pub/de/suche. Retrieved 29 September 2026.
  • Sandoz Group AG — Financial Report 2025, note 34 “Principal Group subsidiaries” (Salutas Pharma GmbH, Barleben, share capital EUR 42.1m, equity interest 100%; HEXAL AG, Holzkirchen, 100%; Sandoz Deutschland GmbH, Nuremberg, 100%) and note 18 (tax matters agreement with Novartis, “As of October 4, 2023”), published 24 February 2026, https://sandoz-com.cms.sandoz.com/sites/default/files/2026-02/Sandoz%20Financial%20Report%202025.pdf. Retrieved 29 September 2026.
  • Presse- und Informationsamt der Bundesregierung — press statement of 26 June 2026 describing Salutas Pharma as “eine Tochtergesellschaft der Hexal AG innerhalb des Schweizer Arzneimittelherstellers Sandoz”, https://www.bundesregierung.de/breg-de/aktuelles/bundeskanzler-salutas-pharma-2445354. Retrieved 29 September 2026.

Data-provider feed — rows as supplied to Zavia for Handelsregister (Commercial Register), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Ultimate HQ
Sandoz Group AG
Switzerland

Registry questions

Frequently asked questions

What does Salutas Pharma GmbH do?

Salutas Pharma GmbH manufactures, packages and distributes finished medicines at two sites in Saxony-Anhalt, Barleben and Osterweddingen, producing solid oral dosage forms including highly potent oncology medicines as well as ointments, creams, gels and low-dose hormone tablets. Its registered object at Amtsgericht Stendal is the manufacture and distribution of medicinal products and other pharmaceutical and biological preparations.

Who owns Salutas Pharma GmbH?

Salutas Pharma GmbH has a single shareholder. The Liste der Gesellschafter filed at Amtsgericht Stendal (HRB 105793), drawn up on 10 March 2020 and admitted to the register folder on 26 March 2020, records Hexal Aktiengesellschaft, Holzkirchen (Amtsgericht München HRB 110375) as holder of all three shares, nominal EUR 42,100,000 in total, or 100 per cent.

Who is Salutas Pharma GmbH's UBO (Ultimate Beneficial Owner)?

No natural-person ultimate beneficial owner has been verified. Germany's Transparenzregister has been closed to public inspection since the Court of Justice of the European Union judgment of 22 November 2022, and the documented ownership chain runs to Sandoz Group AG, a listed Swiss company, with no natural person identified as holding a qualifying interest.

What is Salutas Pharma GmbH's company registration number?

Salutas Pharma GmbH's registration number is HRB 105793 Stendal, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.

Is Salutas Pharma GmbH still an active company?

Salutas Pharma GmbH's status on Handelsregister (Commercial Register) is listed as active.

What is Salutas Pharma GmbH's registered address?

The registered address on file for Salutas Pharma GmbH is Barleben, Germany.

What is Salutas Pharma GmbH's revenue?

No entity-level revenue, profit or balance-sheet figure is publicly available free of charge. Salutas Pharma GmbH has not deposited its own annual accounts in the Bundesanzeiger; for financial years 2014 to 2021 it published exemption notices under sections 264(3) and 264b HGB, the last on 29 October 2021, and it is party to a profit-transfer agreement with its parent.

Is Salutas Pharma GmbH listed on a stock exchange?

Salutas Pharma GmbH is not listed on any stock exchange; it is a private German GmbH with share capital of EUR 42,100,000. Its ultimate parent, Sandoz Group AG, is listed on the SIX Swiss Exchange.

Who are the officers/directors of Salutas Pharma GmbH?

The commercial register records two Geschäftsführer (Claudia Lövenich and Grit Antje Müller) and three Prokuristen (Gregor Markus Tamm, Folker Heinicke and Katrin Seidel) as at 29 September 2026. The company is represented by two Geschäftsführer jointly or by one Geschäftsführer together with a Prokurist, and it also has a supervisory board whose latest list of members was announced on 11 June 2026.

Does Salutas Pharma GmbH have a parent company or subsidiaries?

Salutas Pharma GmbH is wholly owned by Hexal Aktiengesellschaft, Holzkirchen, and sits within the Sandoz group under Sandoz Deutschland GmbH, Nuremberg, with Sandoz Group AG, Basel (CHE-433.164.136), as ultimate parent. A Beherrschungs- und Ergebnisabführungsvertrag with Hexal Aktiengesellschaft dated 21 April 2005 is recorded on the register, and the ultimate parent changed from Novartis to Sandoz Group AG with the spin-off of 4 October 2023.

Can Zavia monitor changes to Salutas Pharma GmbH's ownership over time?

This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Salutas Pharma GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access Salutas Pharma GmbH's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Salutas Pharma GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 11 September 2026.

This website uses cookies to improve your web experience.